Association between Novel Hematological Indices and Measures of Disease Activity in Patients with Rheumatoid Arthritis

Jung-Yoon Choe, Chan Uk Lee, Seong-Kyu Kim, Jung-Yoon Choe, Chan Uk Lee, Seong-Kyu Kim

Abstract

Background and Objectives: Hematological indices have been known to be available markers used for evaluating disease activity in rheumatoid arthritis (RA). This study serves to verify the association between four different hematological indices and disease activity measures in patients with RA. Materials and Methods: The study included 257 female RA patients and 71 age-matched female controls. Four hematological indices, namely systemic immune-inflammation index (SII), neutrophil-to-hemoglobin and lymphocyte (NHL) score, neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR), were evaluated. Composite measures of RA included Disease Activity Score 28 joints (DAS28), the simplified disease activity index (SDAI), and the clinical disease activity index (CDAI). Results: Patients with RA showed statistically higher SII, NHL score, NLR, and PLR compared with controls. SII and NHL score were significantly associated with DAS28 erythrocyte sedimentation rate (DAS28-ESR), DAS28 C-reactive protein (DAS28-CRP), CDAI, and SDAI, whereas NLR was related to DAS28-CRP, CDAI, and SDAI. SII, NHL score, and NLR tended to increase as disease activity based on DAS28-ESR, DAS28-CRP, and CDAI worsened. In the analysis using receiver operating characteristic curve of hematological indices for diagnostic accuracy, the area under the curve was 0.703 (95% confidence interval, CI 0.637−0.769, p < 0.001) for SII and 0.705 (95% CI 0.639−0.770, p < 0.001) for NHL score, which showed acceptable potential for the diagnosis of RA. Four hematological indices showed weak potential for the detection of remission. Conclusions: The present study results showed that SII and NHL scores might be useful markers that adequately reflect disease activity and lead to more accurate diagnosis in RA.

Keywords: composite measure; disease activity; hematological index; rheumatoid arthritis.

Conflict of interest statement

There are no financial and non-financial conflict of interest for any of the authors that are relevant to the work conducted or reported in this manuscript.

Figures

Figure 1
Figure 1
Receiver operating characteristic curve analysis of hematological indices in the diagnosis of RA. Abbreviation: SII, systemic immune-inflammation index; NHL, neutrophil-to-hemoglobin and lymphocyte; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio.

References

    1. Aletaha D., Smolen J.S. Diagnosis and Management of Rheumatoid Arthritis: A Review. JAMA. 2018;320:1360–1372. doi: 10.1001/jama.2018.13103.
    1. Guo Q., Wang Y., Xu D., Nossent J., Pavlos N.J., Xu J. Rheumatoid arthritis: Pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018;6:15. doi: 10.1038/s41413-018-0016-9.
    1. Anderson J.K., Zimmerman L., Caplan L., Michaud K. Measures of rheumatoid arthritis disease activity: Patient (PtGA) and Provider (PrGA) Global Assessment of Disease Activity, Disease Activity Score (DAS) and Disease Activity Score with 28-Joint Counts (DAS28), Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), Patient Activity Score (PAS) and Patient Activity Score-II (PASII), Routine Assessment of Patient Index Data (RAPID), Rheumatoid Arthritis Disease Activity Index (RADAI) and Rheumatoid Arthritis Disease Activity Index-5 (RADAI-5), Chronic Arthritis Systemic Index (CASI), Patient-Based Disease Activity Score With ESR (PDAS1) and Patient-Based Disease Activity Score without ESR (PDAS2), and Mean Overall Index for Rheumatoid Arthritis (MOI-RA) Arthritis Care. Res. 2011;63((Suppl. 11)):S14–S36.
    1. van der Heijde D.M., van ‘t Hof M., van Riel P.L., van de Putte L.B. Development of a disease activity score based on judgment in clinical practice by rheumatologists. J. Rheumatol. 1993;20:579–581.
    1. Smolen J.S., Breedveld F.C., Schiff M.H., Kalden J.R., Emery P., Eberl G., van Riel P.L., Tugwell P. A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology. 2003;42:244–257. doi: 10.1093/rheumatology/keg072.
    1. Aletaha D., Smolen J. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): A review of their usefulness and validity in rheumatoid arthritis. Clin. Exp. Rheumatol. 2005;23:S100–S108.
    1. Boilard E., Nigrovic P.A., Larabee K., Watts G.F., Coblyn J.S., Weinblatt M.E., Massarotti E.M., Remold-O’Donnell E., Farndale R.W., Ware J., et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science. 2010;327:580–583. doi: 10.1126/science.1181928.
    1. Scapini P., Cassatella M.A. Social networking of human neutrophils within the immune system. Blood. 2014;124:710–719. doi: 10.1182/blood-2014-03-453217.
    1. Gabay C., Kushner I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 1999;340:448–454. doi: 10.1056/NEJM199902113400607.
    1. Maden M., Pamuk G.E., Pamuk Ö.N. Development of Atherosclerotic Cardiovascular Mortality in Gouty Arthritis and Rheumatoid Arthritis Patients: Are They Associated With Mean Platelet Volume and Neutrophil-Lymphocyte Ratio? A Comparative Study. Arch. Rheumatol. 2017;32:39–45. doi: 10.5606/ArchRheumatol.2017.6033.
    1. Uslu A.U., Küçük A., Şahin A., Ugan Y., Yılmaz R., Güngör T., Bağcacı S., Küçükşen S. Two new inflammatory markers associated with Disease Activity Score-28 in patients with rheumatoid arthritis: Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio. Int. J. Rheum. Dis. 2015;18:731–735. doi: 10.1111/1756-185X.12582.
    1. Sargin G., Senturk T., Yavasoglu I., Kose R. Relationship between neutrophil-lymphocyte, platelet-lymphocyte ratio and disease activity in rheumatoid arthritis treated with rituximab. Int. J. Rheum. Dis. 2018;21:2122–2127. doi: 10.1111/1756-185X.13400.
    1. Tekeoğlu İ., Gürol G., Harman H., Karakeçe E., Çiftçi İ.H. Overlooked hematological markers of disease activity in rheumatoid arthritis. Int. J. Rheum. Dis. 2016;19:1078–1082. doi: 10.1111/1756-185X.12805.
    1. Yolbas S., Yildirim A., Gozel N., Uz B., Koca S.S. Hematological Indices May Be Useful in the Diagnosis of Systemic Lupus Erythematosus and in Determining Disease Activity in Behçet’s Disease. Med. Princ. Pract. 2016;25:510–516. doi: 10.1159/000447948.
    1. Mercan R., Bitik B., Tufan A., Bozbulut U.B., Atas N., Ozturk M.A., Haznedaroglu S., Goker B. The Association Between Neutrophil/Lymphocyte Ratio and Disease Activity in Rheumatoid Arthritis and Ankylosing Spondylitis. J. Clin. Lab. Anal. 2016;30:597–601. doi: 10.1002/jcla.21908.
    1. Fu H., Qin B., Hu Z., Ma N., Yang M., Wei T., Tang Q., Huang Y., Huang F., Liang Y., et al. Neutrophil- and platelet-to-lymphocyte ratios are correlated with disease activity in rheumatoid arthritis. Clin. Lab. 2015;61:269–273. doi: 10.7754/Clin.Lab.2014.140927.
    1. Lee H.N., Kim Y.K., Kim G.T., Ahn E., So M.W., Sohn D.H., Lee S.G. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as predictors of 12-week treatment response and drug persistence of anti-tumor necrosis factor-α agents in patients with rheumatoid arthritis: A retrospective chart review analysis. Rheumatol. Int. 2019;39:859–868. doi: 10.1007/s00296-019-04276-x.
    1. Kim J.W., Jung J.Y., Suh C.H., Kim H.A. Systemic immune-inflammation index combined with ferritin can serve as a reliable assessment score for adult-onset Still’s disease. Clin. Rheumatol. 2021;40:661–668. doi: 10.1007/s10067-020-05266-2.
    1. Kim Y., Choi H., Jung S.M., Song J.J., Park Y.B., Lee S.W. Systemic immune-inflammation index could estimate the cross-sectional high activity and the poor outcomes in immunosuppressive drug-naïve patients with antineutrophil cytoplasmic antibody-associated vasculitis. Nephrology. 2019;24:711–717. doi: 10.1111/nep.13491.
    1. Wu J., Yan L., Chai K. Systemic immune-inflammation index is associated with disease activity in patients with ankylosing spondylitis. J. Clin. Lab. Anal. 2021;35:e23964. doi: 10.1002/jcla.23964.
    1. Kim H.J., Lee J.H., Jang S.Y., Bae M.H., Yang D.H., Park H.S., Cho Y.K., Jeong M.H., Park J.S., Kim H.S., et al. Prognostic value of novel neutrophil-to-hemoglobin and lymphocyte score in patients with acute myocardial infarction. Eur. J. Inflamm. 2021;19:20587392211039095. doi: 10.1177/20587392211039095.
    1. Aletaha D., Neogi T., Silman A.J., Funovits J., Felson D.T., Bingham C.O., Birnbaum N.S., Burmester G.R., Bykerk V.P., Cohen M.D., et al. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis. Rheum. 2010;62:2569–2581. doi: 10.1002/art.27584.
    1. Kaplan M.J. Role of neutrophils in systemic autoimmune diseases. Arthritis. Res. Ther. 2013;15:219. doi: 10.1186/ar4325.
    1. Wright H.L., Moots R.J., Edwards S.W. The multifactorial role of neutrophils in rheumatoid arthritis. Nat. Rev. Rheumatol. 2014;10:593–601. doi: 10.1038/nrrheum.2014.80.
    1. Smith T.L., Weyrich A.S. Platelets as central mediators of systemic inflammatory responses. Thromb. Res. 2011;127:391–394. doi: 10.1016/j.thromres.2010.10.013.
    1. Olumuyiwa-Akeredolu O.O., Page M.J., Soma P., Pretorius E. Platelets: Emerging facilitators of cellular crosstalk in rheumatoid arthritis. Nat. Rev. Rheumatol. 2019;15:237–248. doi: 10.1038/s41584-019-0187-9.
    1. Symmons D.P., Farr M., Salmon M., Bacon P.A. Lymphopenia in rheumatoid arthritis. J. R. Soc. Med. 1989;82:462–463. doi: 10.1177/014107688908200806.
    1. Ponchel F., Morgan A.W., Bingham S.J., Quinn M., Buch M., Verburg R.J., Henwood J., Douglas S.H., Masurel A., Conaghan P., et al. Dysregulated lymphocyte proliferation and differentiation in patients with rheumatoid arthritis. Blood. 2002;100:4550–4556. doi: 10.1182/blood-2002-03-0671.
    1. Ganz T. Anemia of Inflammation. N. Engl. J. Med. 2019;381:1148–1157. doi: 10.1056/NEJMra1804281.
    1. Wilson A., Yu H.T., Goodnough L.T., Nissenson A.R. Prevalence and outcomes of anemia in rheumatoid arthritis: A systematic review of the literature. Am. J. Med. 2004;116((Suppl. 7A)):50S–57S. doi: 10.1016/j.amjmed.2003.12.012.
    1. Satis S. New Inflammatory Marker Associated with Disease Activity in Rheumatoid Arthritis: The Systemic Immune-Inflammation Index. Curr. Health Sci. J. 2021;47:553–557.
    1. Cheung P.P., Mari K., Devauchelle-Pensec V., Jousse-Joulin S., D’Agostino M.A., Chalès G., Gaudin P., Mariette X., Saraux A., Dougados M. Predictive value of tender joints compared to synovitis for structural damage in rheumatoid arthritis. RMD Open. 2016;2:e000205. doi: 10.1136/rmdopen-2015-000205.
    1. Zengin O., Onder M.E., Kalem A., Bilici M., Türkbeyler I.H., Ozturk Z.A., Kisacik B., Onat A.M. New inflammatory markers in early rheumatoid arthritis. Z. Rheumatol. 2018;77:144–150. doi: 10.1007/s00393-016-0187-y.
    1. Lee Y.H. Association between the Neutrophil-to-lymphocyte Ratio, and Platelet-to-lymphocyte Ratio and Rheumatoid Arthritis and their Correlations with the Disease Activity: A Meta-analysis. J. Rheum. Dis. 2018;25:169–178. doi: 10.4078/jrd.2018.25.3.169.
    1. Zhang Y., Yin Y., Kuai S., Shan Z., Pei H., Wang J. Combination of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as diagnostic biomarker for rheumatoid arthritis. Int. J. Clin. Exp. Med. 2016;9:22076–22081.
    1. Jin Z., Cai G., Zhang P., Li X., Yao S., Zhuang L., Ren M., Wang Q., Yu X. The value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as complementary diagnostic tools in the diagnosis of rheumatoid arthritis: A multicenter retrospective study. J. Clin. Lab. Anal. 2021;35:e23569. doi: 10.1002/jcla.23569.
    1. Karimifar M., Salesi M., Farajzadegan Z. The association of anti-CCP1 antibodies with disease activity score 28 (DAS-28) in rheumatoid arthritis. Adv. Biomed. Res. 2012;1:30. doi: 10.4103/2277-9175.98156.
    1. Shakiba Y., Koopah S., Jamshidi A.R., Amirzargar A.A., Massoud A., Kiani A., Nicknam M.H., Nazari B., Nikbin B. Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: Evaluation of clinical value and association with disease activity. Iran. J. Allergy Asthma Immunol. 2014;13:147–156.
    1. Targońska-Stępniak B., Zwolak R., Piotrowski M., Grzechnik K., Majdan M. The Relationship between Hematological Markers of Systemic Inflammation (Neutrophil-To-Lymphocyte, Platelet-To-Lymphocyte, Lymphocyte-To-Monocyte Ratios) and Ultrasound Disease Activity Parameters in Patients with Rheumatoid Arthritis. J. Clin. Med. 2020;9:2760. doi: 10.3390/jcm9092760.
    1. Sokka T., Toloza S., Cutolo M., Kautiainen H., Makinen H., Gogus F., Skakic V., Badsha H., Peets T., Baranauskaite A., et al. Women, men, and rheumatoid arthritis: Analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res. Ther. 2009;11:R7.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi